Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Second Sight Medical Products, Inc. - Common Stock (NQ:EYES)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 30, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 4.080 (10)
Ask (Size) 4.280 (1)
Prev. Close 4.140
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 54,978,465
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Vivani Announces Trading under New Ticker Symbol (Nasdaq: VANI)
From Vivani Medical, Inc.
Via Business Wire
Second Sight Medical Products Announces Successful Completion of its Merger with Nano Precision Medical and its Name Change to Vivani Medical, Inc.
From Second Sight Medical Products, Inc.
Via Business Wire

Performance

More News

Read More
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Why GigaCloud Technology Jumped 206%; Here Are 79 Biggest Movers From Yesterday
Via Benzinga
Why Bed Bath & Beyond Is Trading Lower By Over 40%, Here Are 55 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
This Healthcare Stock Is Trading Higher By 148%: Here Are 40 Stocks Moving Premarket
Via Benzinga
Second Sight Medical Products, Inc. Announces Shareholder Approval for Proposed Merger with Nano Precision Medical, Inc. and other Results of 2022 Annual Meeting
From Second Sight Medical Products, Inc.
Via Business Wire
Boeing And 24 Stocks Moving Premarket
Via Benzinga
Second Sight Medical Products Announces Year Four NIH Funding of its Orion Study
From Second Sight Medical Products, Inc.
Via Business Wire
3 Stocks Under $3 Insiders Are Aggressively Buying
Via Benzinga
3 Stocks Under $3 Insiders Are Aggressively Buying
Via Benzinga
88 Biggest Movers From Yesterday
Via Benzinga
Insiders Buy Around $2M Of 2 Penny Stocks
Via Benzinga
Nano Precision Medical Co-Founder and CEO Discusses Proposed Second Sight Merger in Interview to Air on Bloomberg U.S. on the RedChip Money Report®
From Second Sight Medical Products, Inc.
Via Business Wire
EYES Stock Investigation: Halper Sadeh LLP Is Investigating Whether the Merger of Second Sight Medical Products, Inc. Is Fair to Shareholders
From Halper Sadeh LLP
Via Business Wire
35 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
51 Biggest Movers From Yesterday
Via Benzinga
EYES Stock Pops on Biotech Merger Plans. 5 Things to Know.
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Second Sight Medical To Merge With AstraZeneca-Backed Nano Precision Medical
Via Benzinga
21 Stocks Moving in Tuesday's Pre-Market Session
Via Benzinga
Second Sight Medical Products and Nano Precision Medical Announce Merger Agreement to Create Leading Therapeutic Implant Company
From Second Sight Medical Products, Inc.
Via Business Wire
61 Biggest Movers From Yesterday
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga

Frequently Asked Questions

Is Second Sight Medical Products, Inc. - Common Stock publicly traded?
Yes, Second Sight Medical Products, Inc. - Common Stock is publicly traded.
What exchange does Second Sight Medical Products, Inc. - Common Stock trade on?
Second Sight Medical Products, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Second Sight Medical Products, Inc. - Common Stock?
The ticker symbol for Second Sight Medical Products, Inc. - Common Stock is EYES on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.